Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Long-Term Investments (2020 - 2023)

Rapid Micro Biosystems' Long-Term Investments history spans 4 years, with the latest figure at $2.9 million for Q4 2023.

  • On a quarterly basis, Long-Term Investments fell 90.23% to $2.9 million in Q4 2023 year-over-year; TTM through Dec 2023 was $2.9 million, a 90.23% decrease, with the full-year FY2023 number at $2.9 million, down 90.23% from a year prior.
  • Long-Term Investments hit $2.9 million in Q4 2023 for Rapid Micro Biosystems, down from $14.6 million in the prior quarter.
  • Over the last five years, Long-Term Investments for RPID hit a ceiling of $35.2 million in Q3 2022 and a floor of $695000.0 in Q4 2020.
  • Historically, Long-Term Investments has averaged $14.2 million across 4 years, with a median of $12.3 million in 2021.
  • Biggest five-year swings in Long-Term Investments: skyrocketed 2512.31% in 2022 and later plummeted 90.23% in 2023.
  • Tracing RPID's Long-Term Investments over 4 years: stood at $695000.0 in 2020, then surged by 1333.96% to $10.0 million in 2021, then soared by 198.92% to $29.8 million in 2022, then plummeted by 90.23% to $2.9 million in 2023.
  • Business Quant data shows Long-Term Investments for RPID at $2.9 million in Q4 2023, $14.6 million in Q3 2023, and $7.2 million in Q2 2023.